MGC Diagnostics Corporation
MGCD
MGCD was delisted on the 28th of December, 2017.
19 hedge funds and large institutions have $7.78M invested in MGC Diagnostics Corporation in 2014 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
1.55% less ownership
Funds ownership: 23.54% → 22% (-1.5%)
10% less funds holding
Funds holding: 21 → 19 (-2)
31% less capital invested
Capital invested by funds: $11.2M → $7.78M (-$3.42M)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$1.08M |
| 2 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
+$110K |
| 3 |
Renaissance Technologies
New York
|
+$94.5K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$47.5K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$34.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$1.27M |
| 2 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
-$590K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$207K |
| 4 |
U
UBS
Zurich,
Switzerland
|
-$83.3K |
| 5 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$56.9K |
MGCD Hedge Fund Activity: Q2 2014 in Review
19 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in MGC Diagnostics Corporation (MGCD) for Q2 2014, worth a combined $7.78M — down 31% from $11.2M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of MGCD and 3 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 8 added.
The largest buyer was Perceptive Advisors, adding an estimated $1.08M. The largest seller was Cadence Capital Management, exiting entirely with an estimated $1.27M sold.
- 19 institutional investors held MGC Diagnostics Corporation (MGCD) as of Q2 2014, down from 21 in Q1 2014.
- Funds reported $7.78M of MGC Diagnostics Corporation stock for Q2 2014, down 31% quarter-over-quarter.
- 3 funds opened new MGC Diagnostics Corporation positions in Q2 2014 and 5 closed out, a net change of -2 holders.
- The largest MGC Diagnostics Corporation buyer in Q2 2014 was Perceptive Advisors, an estimated $1.08M added.
- The largest MGC Diagnostics Corporation seller in Q2 2014 was Cadence Capital Management, an estimated $1.27M sold.
Based on aggregated 13F filings for Q2 2014.